References
- Miller K D, Jones E, Yanovski J A, et al. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998; 351: 871–5
- Carr A, Samaras K, Chisolm D J, Cooper D A. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance. Lancet 1998; 351: 1881–3
- Warren K J, Boxwell D E, Kim N Y, Drolet B A. Nevirapine-associated Stevens-Johnson syndrome. Lancet 1998; 351: 567
- Zerboni R, Angius A G, Cusini M, et al. Lamivudine-induced paronychia. Lancet 1998; 351: 1256
- Bouscarat F, Bouchard C, Bouhour D. Paronychia and pyogenic granuloma of the great toes in patients treated with indinavir. N Engl J Med 1998; 338: 1776–7
- Duval X, Chosidow O, Semah F, et al. Lamotrigine versus carbamazepine in epilepsy. Lancet 1995; 345: 1301–2
- Page R L, O'Neil M G, Yarbrough D R, Conradi S. Fatal toxic epidermal necrolysis is related to lamotrigine administration. Pharmacotherapy 1998; 18: 392–8
- Cribier B, Marquart-Elbaz C, Lipsker D, et al. Chronic buccal ulceration induced by nicorandil. Br J Dermatol 1998; 138: 372–3
- Correia O, Delgado L. Bullous photodermatosis after lomefloxacin. Arch Dermatol 1994; 130: 808–9
- Poh-Fitzpatrick M B. Lomefloxacin photosensitivity. Arch Dermatol 1994; 130: 261
- Le Cleach L, Chosidow O, Peytavin G, et al. Skin blue-black pigmentation of the legs associated with long-term pefloxacin therapy. Arch Dermatol 1995; 131: 856–7
- Senet P, Aractingi S, Porneuf M, et al. Hydroxyurea-induced dermatomyositis-like eruption. Br J Dermatol 1995; 133: 455–9
- Callot-Mellot C, Bodemer C, Chosidow O, et al. Cutaneous carcinoma during long term hydroxyurea therapy: a report of 5 cases. Arch Dermatol 1996; 132: 1395–7
- Asnis L A, Gaspari A A. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 1995; 33: 393–410
- Bachmeyer C, Chaibi P, Aractingi S. Neutrophilic eccrine hidradenitis induced by granulocyte colony-stimulating factor. Br J Dermatol 1998; 138: 354–5
- Paul C, Giachetti S, Pinquier L, et al. Cutaneous effects of granulocyte colony-stimulating factor in healthy volunteers. Arch Dermatol 1998; 134: 111–2
- Surville-Barland J, Caumes E, Ankri A, et al. Bleomycin-induced digital gangrene. Eur J Dermatol 1998; 8: 221, (letter)
- Bonnetblanc J M. Acrosyndromes médicamenteux. Ann Dermatol Venereol 1998; 125: 529–32
- Bachmayer C, Farge D, Gluckman E, et al. Raynaud's phenomenon and digital necrosis induced by interferonalpha. Br J Dermatol 1996; 135: 481–3
- Linden D. Severe Raynaud's phenomenon associated with interferon-β treatment for multiple sclerosis. Lancet 1998; 352: 878–9
- Pechère M, Zulian G B, Vogel J J, et al. Fingertip necrosis during chemotherapy with bleomycin, vincristin and methotrexate for HIV-related Kaposi's sarcoma. Br J Dermatol 1996; 134: 378–9
- Marinella M A, Berrettoni B A. Digital necrosis associated with dexi'enfluramine. N Engl J Med 1997; 337: 1776–7
- Bastuji-Garin S, Toly P, Picard-Dahan C, et al. Drugs associated with bullous pemphigoid. Arch Dermatol 1996; 132: 272–6
- Roujeau J C, Bioulac-Sage P, Bourseau C, et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 1991; 127: 1333–8
- Callot V, Roujeau J C, Bagot M, et al. Drug-induced pseudolymphoma and hypersensitivity syndrome. Arch Dermatol 1996; 132: 1315–21
- Le Cleach L, Fillet A M, Chosidow O. Human herpesvirus 6 and 7: new roles yet to be discovered?. Arch Dermatol 1998; 134: 1155–7
- Beneton N, Bocquet H, Cosnes A, et al. Benefit-risk assessment of acne therapies. Lancet 1997; 349: 1251–2
- Shapiro L E, Knowles S R, Shear N H. Comparative safety of tetracycline, minocycline, and doxycycline. Arch Dermatol 1997; 133: 1224–30